Brain changes found in depression with chronic pain comorbidity

When depression and chronic pain arrive together in the same patient, clinicians have long observed that both conditions become harder to treat, yet the neurological basis of this troubling pairing has remained stubbornly unclear. A new resting-state functional magnetic resonance imaging study published in BMC Psychiatry now offers a detailed map of how the co-occurrence of these two conditions alters brain activity, revealing distinct patterns of neural dysfunction in temporal, striatal, and somatosensory regions that set patients with depression-chronic pain comorbidity apart from those suffering from depression alone.

The research, led by Zhihan Jiang and Xinlin Wang of the Department of Psychosomatic Medicine at Shanghai Tongji Hospital, Tongji University School of Medicine, together with colleagues in Shanghai, Huzhou, and Guangzhou, addressed a question that carries enormous clinical weight. Depression frequently co-occurs with chronic pain, and this overlap is associated with worse clinical outcomes and treatment resistance. Understanding the brain-level signature of this comorbidity could ultimately help clinicians identify which patients are at greatest risk and design more targeted interventions.

The study recruited three groups of participants matched for age, gender, and education level: 35 depression patients with chronic pain, referred to as the DCP group; 39 depression patients without chronic pain, the DNCP group; and 45 healthy controls. Each participant underwent a resting-state functional magnetic resonance imaging scan, a technique that measures spontaneous brain activity while the participant lies still and performs no explicit task. This approach is particularly valuable in psychiatry because it captures the brain’s intrinsic functional organization rather than performance on any specific cognitive exercise. In addition to imaging, participants completed the Hamilton Depression Rating Scale, a standard clinical measure of depressive symptom severity, and the Visual Analog Scale of pain, which quantifies subjective pain intensity.

The final analysis included 34 patients in the depression-with-pain group, 38 patients with depression alone, and all 45 healthy controls. The researchers applied two complementary measures of local brain function. The first, the amplitude of low-frequency fluctuations, or ALFF, quantifies the intensity of spontaneous neural activity in a given region by measuring fluctuations in the blood oxygenation signal at very low frequencies, typically below 0.1 hertz. Regions with higher ALFF are generally interpreted as showing greater spontaneous neural activity. The second measure, regional homogeneity, or ReHo, assesses the degree to which activity in a given voxel is synchronized with its immediate neighbors, providing an index of local functional coherence. Because these two metrics probe different aspects of resting-state function, examining both in parallel gives a richer picture than either alone.

The comparison between the two patient groups produced a clear and internally consistent result. Compared with depressed patients who did not have chronic pain, those with comorbid chronic pain showed significantly decreased ALFF in two adjacent regions of the left temporal lobe: the left middle temporal gyrus and the left inferior temporal gyrus. These regions are traditionally associated with higher-order sensory processing and semantic and visual interpretation, but growing evidence implicates them in the cognitive and affective evaluation of bodily states. Reduced spontaneous activity in these areas suggests that when depression is accompanied by persistent pain, the temporal cortical machinery involved in integrating sensory and emotional information may be operating at a lower functional level.

The ReHo findings painted a more nuanced picture, revealing both decreases and increases in local synchronization depending on the region involved. Patients with depression and chronic pain showed lower local synchronization in the bilateral putamen and caudate, two core components of the striatum, the brain’s principal input structure for basal ganglia circuits. The striatum is central to reward processing, motivation, and habit formation, and its disruption is a well-established feature of depression. The new data suggest that when chronic pain is layered onto depression, this reward-related dysfunction extends into a measurable loss of local coordination within striatal circuits, potentially linking the blunted motivation and anhedonia of depression with the persistence of pain perception.

At the same time, the comorbid group displayed higher regional homogeneity in the left postcentral gyrus and the bilateral cuneus. The postcentral gyrus houses the primary somatosensory cortex, the region that processes tactile and bodily sensation, and heightened local synchrony there fits naturally with the clinical reality of chronic pain, in which somatosensory circuits become sensitized and persistently active. The cuneus, located in the occipital lobe and involved in visual processing, has also been repeatedly implicated in pain-related imaging studies, possibly reflecting attentional and perceptual amplification of bodily signals. Together, these increases point to a brain in which pain-processing regions are running hot even at rest, while reward and temporal integrative regions are running cold.

To probe whether the regions showing ALFF differences were also communicating abnormally with the rest of the brain, the researchers used the left middle temporal gyrus and left inferior temporal gyrus as seed regions for exploratory whole-brain functional connectivity analyses, which test how strongly activity in the seed correlates with activity elsewhere. Notably, no significant functional connectivity differences emerged between the comorbid and depression-only groups. This null result suggests that the neural alterations accompanying depression-chronic pain comorbidity may be primarily local in nature, involving the intensity and coherence of regional activity rather than long-range network integration. The authors framed these findings as providing further insight into the neural alterations associated with the comorbidity and as a foundation for future mechanistic investigations.

Statistical rigor was built into the analysis at multiple levels. Feature associations between brain measures and clinical scores were assessed using Pearson correlation analysis with Benjamini-Hochberg correction for multiple comparisons, a procedure that controls the false discovery rate and reduces the risk that apparently significant associations arise by chance alone. The demographic matching of the three groups on age, gender, and education helps ensure that the observed neural differences cannot be attributed to these basic variables, strengthening the inference that they relate specifically to the presence or absence of chronic pain in depressed patients.

The clinical implications of the study are significant. Chronic pain and depression are among the most common co-occurring conditions in medicine, and patients carrying both diagnoses frequently respond poorly to standard antidepressant treatment. By identifying specific neural markers, reduced spontaneous activity in temporal regions, desynchronized striatal function, and hyper-synchronized somatosensory and occipital activity, the study provides concrete biological targets that could guide future work on biomarkers, treatment stratification, and mechanism-based therapies. If the striatal findings, for example, prove reproducible in larger samples, they might motivate treatment approaches that jointly address reward dysfunction and pain sensitization rather than treating the two conditions in isolation.

The study also has important limitations inherent in its design. As a cross-sectional resting-state investigation with moderately sized groups, it cannot determine whether the observed brain differences are a cause or a consequence of the comorbidity, and the exploratory functional connectivity analyses yielded no group differences, leaving open the question of how these local alterations relate to broader network dynamics. The authors acknowledge that their results serve as a basis for future mechanistic investigations rather than a definitive explanation. Longitudinal studies tracking patients over time, along with multimodal imaging that combines functional measures with structural and neurochemical data, will be needed to clarify how these regional signatures emerge and whether they predict treatment response.

Funding for the work came from the National Key Research and Development Program of China, the Shanghai Shen-Kang Hospital Development Center Program, the National Natural Science Foundation of China, and the National Postdoctoral Program for Innovative Talents. The study was approved by the Shanghai Tongji Hospital Ethics Committee, and all participants provided informed consent before data collection. The design adhered to the principles of the Declaration of Helsinki, and the authors declared no competing interests.

For a field in which depression and chronic pain have often been studied separately despite their frequent co-occurrence, this research represents a meaningful step toward treating the intersection as a distinct clinical and neurobiological entity. The picture that emerges is one of a brain whose temporal integrative regions and striatal reward circuits are dampened, while its somatosensory and visual pain-processing regions are amplified, a pattern that may ultimately explain why patients with both conditions suffer more and respond less to existing treatments.